GlassScriptPhysician profile
Daniel R Okeefe
NPI 1083951420
$698.94
in general payments reported to CMS, 2019-2025
12 companies · $415 in 2025
The $415 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $224 · 2024: $59.77 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $698.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $122.43 | 2023-2025 | Avvigo Guidance System, Rotapro, Synergy |
| Orthofix Medical, INC. | $89.72 | 2025 | Physio-Stim |
| Amgen INC. | $80.43 | 2024-2025 | Repatha |
| Astrazeneca Pharmaceuticals LP | $77.93 | 2023-2025 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $59.31 | 2023-2025 | Camzyos, Eliquis |
| Catalyst Orthoscience | $51.04 | 2023 | Csr & R1 Reverse Total Shoulder Systems, R1 Reverse Total Shoulder, Archer 3d Software |
| Abbott Laboratories | $48.04 | 2023-2024 | Diamondback Coronary, Cardiomems |
| Novartis Pharmaceuticals Corporation | $47.88 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.16 | 2023-2025 | Jardiance |
| Edwards Lifesciences Corporation | $33.13 | 2023 | Pascal |
| Stryker Corporation | $29.63 | 2025 | Flowtriever |
| Heartflow, INC. | $17.24 | 2023 | Ffrct |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Okeefe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.